Related Experiment Video
Updated: Jan 2, 2026
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Review: Contemporary biological therapies for cardiovascular diseases
1Pharmacist, Tahir Heart Institute, Rabwah.
Insights
Biological therapies like stem cell and gene therapy show promise for treating cardiovascular diseases (CVDs). These innovative treatments aim to regenerate heart tissue and improve cardiac function, offering new hope beyond traditional methods.
Area of Science:
- Cardiology
- Regenerative Medicine
- Molecular Biology
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of mortality.
- Current treatments alleviate symptoms but do not offer a cure.
- Advances in molecular and pathophysiological understanding enable new biological therapies.
Purpose of the Study:
- To review the role of biological therapies in treating cardiovascular diseases.
- To explore the potential of stem cell therapy and gene therapy for CVDs.
- To highlight recent advancements and clinical trial outcomes.
Main Methods:
- Review of preclinical and clinical trial data on stem cell therapy for myocardial regeneration.
- Analysis of gene therapy approaches for heart failure, ischemic disease, and arrhythmias.
- Evaluation of advancements in vector technology and cell delivery methods.
Main Results:
- Stem cell therapy shows variable success in regenerating damaged myocardium, with improved outcomes linked to delivery methods.
- Gene therapy, utilizing improved vectors, enhances transfection and transgene expression, showing promise for various cardiac conditions.
- Clinical trials indicate improved cardiac function with gene therapies promoting angiogenesis.
Conclusions:
- Stem cell and gene therapies represent promising biological treatments for cardiovascular diseases.
- Continued research and technological advancements are crucial for optimizing these therapies.
- These approaches offer potential for improved patient outcomes and disease management.
Abstract:
Cardiovascular diseases are top cause of mortality in the world. Current interventional therapy and pharmacotherapy may alleviate symptoms or slow disease progression but are unable to cure or treat them. Molecular and pathophysiological advances have paved the way for contemporary biological therapies to be tested and standardized for the treatment of these diseases. Stem cells therapy and gene therapy has shown promise in the treatment of CVDs. Various types of stem cells used in cardiac conditions like myocardial infarction with the aim of regenerating the damaged myocardium have had variable success rates in clinical and preclinical trials. Improvements in methods and routes of cell delivery have improved clinical outcomes. Gene therapy employs therapeutic genes to treat diseases. Advances in vectors have improved transfection efficiencies and transgene expression and enhanced role in Heart failure, ischemic disease as well as arrhythmias. Clinical trials have shown improved cardiac function upon treatment with genes which promote angiogenesis. The current review looks at the role of these biological therapies in cardiovascular diseases.
